erythrosine and indazoles

erythrosine has been researched along with indazoles in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ko, FN; Kuo, SC; Lee, FY; Teng, CM; Wu, CC1
Arsenio, L; De Gregorio, M; Maraini, G; Nuzzi, G; Venturini, I1
Hasui, M; Kobayashi, Y; Taniuchi, S; Tsuji, S; Yamamoto, A1
Dismuke, WM; Ellis, DZ; Sharif, NA1
Hung, CC; Liou, HH1
Currier, GF; Dandajena, TC; Disch, B; Ihnat, MA; Thorpe, J1

Trials

1 trial(s) available for erythrosine and indazoles

ArticleYear
Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Acta ophthalmologica Scandinavica, 1997, Volume: 75, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blood-Retinal Barrier; Cell Membrane Permeability; Cross-Over Studies; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Fluorescein; Fluoresceins; Fluorescent Dyes; Fluorophotometry; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Sample Size; Vitreous Body

1997

Other Studies

5 other study(ies) available for erythrosine and indazoles

ArticleYear
YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
    European journal of pharmacology, 1997, Feb-12, Volume: 320, Issue:2-3

    Topics: Adenosine Diphosphate; Animals; Bleeding Time; Blood Coagulation; Blood Platelets; Disease Models, Animal; Enzyme Activation; Fibrinolytic Agents; Fluorescein; Fluoresceins; Guanylate Cyclase; Indazoles; Male; Mice; Mice, Inbred ICR; Nitric Oxide; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Serum Globulins; Solubility; Thrombosis

1997
Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole.
    Nitric oxide : biology and chemistry, 2002, Volume: 7, Issue:4

    Topics: Adolescent; Adult; Anti-Infective Agents; Calcimycin; Child; Child, Preschool; Enzyme Inhibitors; Fluoresceins; Fluorescence; Granulomatous Disease, Chronic; Humans; Hydrogen Peroxide; Indazoles; Infant; Isothiuronium; Lipopolysaccharides; Male; Neutrophils; Nitric Oxide; Trimethoprim, Sulfamethoxazole Drug Combination

2002
Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
    Investigative ophthalmology & visual science, 2009, Volume: 50, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Benzoates; Cell Size; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activators; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Guanylate Cyclase; Humans; Indazoles; Large-Conductance Calcium-Activated Potassium Channels; Microscopy, Confocal; Nitric Oxide; Oxadiazoles; Quinoxalines; Trabecular Meshwork

2009
YC-1, a novel potential anticancer agent, inhibit multidrug-resistant protein via cGMP-dependent pathway.
    Investigational new drugs, 2011, Volume: 29, Issue:6

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Fluoresceins; Fluorescent Dyes; Gene Expression Regulation; Humans; Indazoles; Nitric Oxide; Reverse Transcriptase Polymerase Chain Reaction; Rhodamine 123; Signal Transduction

2011
Hypoxia triggers a HIF-mediated differentiation of peripheral blood mononuclear cells into osteoclasts.
    Orthodontics & craniofacial research, 2012, Volume: 15, Issue:1

    Topics: Acid Phosphatase; Biomarkers; Blotting, Western; Bone Remodeling; Cell Culture Techniques; Cell Differentiation; Cell Hypoxia; Cell Proliferation; Cell Survival; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Fluoresceins; Fluorescent Dyes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Isoenzymes; Leukocytes, Mononuclear; Osteoblasts; Osteoclasts; RANK Ligand; Tartrate-Resistant Acid Phosphatase; Up-Regulation; Vascular Endothelial Growth Factor A

2012